Outlook Therapeutics Inc banner

Outlook Therapeutics Inc
SWB:41ON

Watchlist Manager
Outlook Therapeutics Inc Logo
Outlook Therapeutics Inc
SWB:41ON
Watchlist
Price: 0.1954 EUR -0.96%
Market Cap: €2.5m

Wall St Price Targets

41ON Price Targets Summary
Outlook Therapeutics Inc

Wall Street analysts forecast 41ON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for 41ON is 0.9548 EUR with a low forecast of 0.1134 EUR and a high forecast of 1.4153 EUR.

Lowest Forecast
Price Target
0.1134 EUR
42% Downside
Average Forecast
Price Target
0.9548 EUR
389% Upside
Highest Forecast
Price Target
1.4153 EUR
624% Upside
Outlook Therapeutics Inc Competitors:
Price Targets
OFIX
Orthofix Medical Inc
90% Upside
VYNE
Vyne Therapeutics Inc
199% Upside
NYXH
Nyxoah SA
241% Upside
1981
Cathay Media and Education Group Inc
50% Upside

Revenue
Forecast

-12% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss
-12% / Year
Past Growth
55% / Year
Estimated Growth
Estimates Accuracy
N/A
Average Beat/Miss

Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-92%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is 41ON's stock price target?
Price Target
0.9548 EUR

According to Wall Street analysts, the average 1-year price target for 41ON is 0.9548 EUR with a low forecast of 0.1134 EUR and a high forecast of 1.4153 EUR.

What is the Revenue forecast for Outlook Therapeutics Inc?
Projected CAGR
55%

Over the last 10 years, the compound annual growth rate for Revenue has been -12%. The projected CAGR for the next 8 years is 55%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett